poly(methyl methacrylate) structure
|
Common Name | poly(methyl methacrylate) | ||
---|---|---|---|---|
CAS Number | 9010-88-2 | Molecular Weight | 200.23200 | |
Density | 1.2 g/mL at 25ºC(lit.) | Boiling Point | 99.5ºC at 760mmHg | |
Molecular Formula | (C5H8O2.C5H8O2)x | Melting Point | 150ºC | |
MSDS | Chinese USA | Flash Point | 15.6ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of poly(methyl methacrylate)Ethyl acrylate-methyl methacrylate copolymer can be used as an excipient, such as sustained-release coating materials, matrix sustained-release tablet binders and retarders. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1]. |
Name | ethyl prop-2-enoate,methyl 2-methylprop-2-enoate |
---|---|
Synonym | More Synonyms |
Description | Ethyl acrylate-methyl methacrylate copolymer can be used as an excipient, such as sustained-release coating materials, matrix sustained-release tablet binders and retarders. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2 g/mL at 25ºC(lit.) |
---|---|
Boiling Point | 99.5ºC at 760mmHg |
Melting Point | 150ºC |
Molecular Formula | (C5H8O2.C5H8O2)x |
Molecular Weight | 200.23200 |
Flash Point | 15.6ºC |
Exact Mass | 200.10500 |
PSA | 52.60000 |
LogP | 1.47100 |
Appearance of Characters | powder |
Index of Refraction | n20/D 1.49 |
Water Solubility | alcohols and aliphatic hydrocarbons: insoluble |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 + H332 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R20/22 |
Safety Phrases | 36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | TR0400000 |
HS Code | 3906100000 |
HS Code | 3906100000 |
---|
Dynamic mechanical thermal analysis studies of polymer films prepared from aqueous dispersion.
Int. J. Pharm. 235(1-2) , 107-11, (2002) Dynamic Mechanical Thermal Analysis of cast and sprayed films of an aqueous dispersion of polymethyl methacrylate (Eudragit NE30D) and mixtures with an aqueous dispersion of ethylcellulose (Aquacoat E... |
|
Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
AAPS PharmSci 3(2) , E14, (2001) This study investigates the crystallization of the endogenous surfactant nonoxynol 100 in Eudragit NE30D-free films during storage and the influences of nonoxynol 100 on the dissolution of diphenhydra... |
|
Physical properties of solid dispersion of a nonsteroidal anti-inflammatory drug (M-5011) with Eudragit E.
Drug Dev. Ind. Pharm. 26(12) , 1271-8, (2000) Some acidic nonsteroidal anti-inflammatory drugs (NSAIDs) are poorly soluble in the stomach. In this study, M-5011, d-2-[4-(3-methyl-2-thienyl) phenyl] propionic acid, was used as a model substance. T... |
EINECS 201-297-1 |
Primal AC 22 |
Primal AC 33 |
Ethyl acrylate methyl methacrylate polymer |
Preparation 2817D |
Eudragit E 30D |
UNII-5KY68S2577 |
UNII-P2OM2Q86BI |
Primal B 52 |